BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9040451)

  • 1. Achievement and safety of a low blood pressure goal in chronic renal disease. The Modification of Diet in Renal Disease Study Group.
    Lazarus JM; Bourgoignie JJ; Buckalew VM; Greene T; Levey AS; Milas NC; Paranandi L; Peterson JC; Porush JG; Rauch S; Soucie JM; Stollar C
    Hypertension; 1997 Feb; 29(2):641-50. PubMed ID: 9040451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study.
    Peterson JC; Adler S; Burkart JM; Greene T; Hebert LA; Hunsicker LG; King AJ; Klahr S; Massry SG; Seifter JL
    Ann Intern Med; 1995 Nov; 123(10):754-62. PubMed ID: 7574193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of diet and antihypertensive therapy on creatinine clearance and serum creatinine concentration in the Modification of Diet in Renal Disease Study.
    J Am Soc Nephrol; 1996 Apr; 7(4):556-66. PubMed ID: 8724889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group.
    Klahr S; Levey AS; Beck GJ; Caggiula AW; Hunsicker L; Kusek JW; Striker G
    N Engl J Med; 1994 Mar; 330(13):877-84. PubMed ID: 8114857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term effects of protein intake, blood pressure, and antihypertensive therapy on glomerular filtration rate in the Modification of Diet in Renal Disease Study.
    J Am Soc Nephrol; 1996 Oct; 7(10):2097-109. PubMed ID: 8915969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the modification of diet in renal disease study.
    Sarnak MJ; Greene T; Wang X; Beck G; Kusek JW; Collins AJ; Levey AS
    Ann Intern Med; 2005 Mar; 142(5):342-51. PubMed ID: 15738453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antihypertensive and renoprotective efficacy and safety of losartan. A long-term study in children with renal disorders.
    Ellis D; Moritz ML; Vats A; Janosky JE
    Am J Hypertens; 2004 Oct; 17(10):928-35. PubMed ID: 15485756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal protection in hypertensive patients: selection of antihypertensive therapy.
    Wenzel RR
    Drugs; 2005; 65 Suppl 2():29-39. PubMed ID: 16398060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary protein restriction, blood pressure control, and the progression of polycystic kidney disease. Modification of Diet in Renal Disease Study Group.
    Klahr S; Breyer JA; Beck GJ; Dennis VW; Hartman JA; Roth D; Steinman TI; Wang SR; Yamamoto ME
    J Am Soc Nephrol; 1995 Jun; 5(12):2037-47. PubMed ID: 7579052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data.
    Jafar TH; Schmid CH; Landa M; Giatras I; Toto R; Remuzzi G; Maschio G; Brenner BM; Kamper A; Zucchelli P; Becker G; Himmelmann A; Bannister K; Landais P; Shahinfar S; de Jong PE; de Zeeuw D; Lau J; Levey AS
    Ann Intern Med; 2001 Jul; 135(2):73-87. PubMed ID: 11453706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of blood pressure control on progressive renal disease in blacks and whites. Modification of Diet in Renal Disease Study Group.
    Hebert LA; Kusek JW; Greene T; Agodoa LY; Jones CA; Levey AS; Breyer JA; Faubert P; Rolin HA; Wang SR
    Hypertension; 1997 Sep; 30(3 Pt 1):428-35. PubMed ID: 9314428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of dietary protein restriction on the progression of moderate renal disease in the Modification of Diet in Renal Disease Study.
    J Am Soc Nephrol; 1996 Dec; 7(12):2616-26. PubMed ID: 8989740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypertension management in chronic kidney disease: translating guidelines into daily practice.
    De Nicola L; Borrelli S; Chiodini P; Zamboli P; Iodice C; Gabbai FB; Conte G; Minutolo R
    J Nephrol; 2011; 24(6):733-41. PubMed ID: 21319133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis.
    Jafar TH; Stark PC; Schmid CH; Landa M; Maschio G; de Jong PE; de Zeeuw D; Shahinfar S; Toto R; Levey AS;
    Ann Intern Med; 2003 Aug; 139(4):244-52. PubMed ID: 12965979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study.
    Esnault VL; Brown EA; Apetrei E; Bagon J; Calvo C; DeChatel R; Holdaas H; Krcmery S; Kobalava Z;
    Clin Ther; 2008 Mar; 30(3):482-98. PubMed ID: 18405787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of hypertension in chronic kidney disease.
    Toto RD
    Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Limitations of analyses based on achieved blood pressure: lessons from the African American study of kidney disease and hypertension trial.
    Davis EM; Appel LJ; Wang X; Greene T; Astor BC; Rahman M; Toto R; Lipkowitz MS; Pogue VA; Wright JT;
    Hypertension; 2011 Jun; 57(6):1061-8. PubMed ID: 21555676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular outcomes in the first trial of antihypertensive therapy guided by self-measured home blood pressure.
    Asayama K; Ohkubo T; Metoki H; Obara T; Inoue R; Kikuya M; Thijs L; Staessen JA; Imai Y;
    Hypertens Res; 2012 Nov; 35(11):1102-10. PubMed ID: 22895063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive and antiproteinuric efficacy of ramipril in children with chronic renal failure.
    Wühl E; Mehls O; Schaefer F;
    Kidney Int; 2004 Aug; 66(2):768-76. PubMed ID: 15253732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension.
    Jamerson KA; Nwose O; Jean-Louis L; Schofield L; Purkayastha D; Baron M
    Am J Hypertens; 2004 Jun; 17(6):495-501. PubMed ID: 15177521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.